D Carassiti1, D R Altmann2, N Petrova1, B Pakkenberg3, F Scaravilli1, K Schmierer1,4. 1. Blizard Institute (Neuroscience), Queen Mary University of London, London, UK. 2. Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK. 3. Research Laboratory for Stereology and Neuroscience, Bispebjerg University Hospital, Copenhagen, Denmark. 4. Neurosciences Clinical Academic Group, The Royal London Hospital, Barts Health NHS Trust, London, UK.
Abstract
AIMS: Indices of brain volume [grey matter, white matter (WM), lesions] are being used as outcomes in clinical trials of patients with multiple sclerosis (MS). We investigated the relationship between cortical volume, the number of neocortical neurons estimated using stereology and demyelination. METHODS: Nine MS and seven control hemispheres were dissected into coronal slices. On sections stained for Giemsa, the cortex was outlined and optical disectors applied using systematic uniform random sampling. Neurons were counted using an oil immersion objective (× 60) following stereological principles. Grey and WM demyelination was outlined on myelin basic protein immunostained sections, and expressed as percentages of cortex and WM respectively. RESULTS: In MS, the mean number of neurons was 14.9 ± 1.9 billion vs. 24.4 ± 2.4 billion in controls (P < 0.011), a 39% difference. The density of neurons was smaller by 28% (P < 0.001) and cortical volume by 26% (P = 0.1). Strong association was detected between number of neurons and cortical volume (P < 0.0001). Demyelination affected 40 ± 13% of the MS neocortex and 9 ± 12% of the WM, however, neither correlated with neuronal loss. Only weak association was detected between number of neurons and WM volume. CONCLUSION: Neocortical neuronal loss in MS is massive and strongly predicted by cortical volume. Cortical volume decline detected in vivo may be similarly indicative of neuronal loss. Lack of association between neuronal density and demyelination suggests these features are partially independent, at least in chronic MS.
AIMS: Indices of brain volume [grey matter, white matter (WM), lesions] are being used as outcomes in clinical trials of patients with multiple sclerosis (MS). We investigated the relationship between cortical volume, the number of neocortical neurons estimated using stereology and demyelination. METHODS: Nine MS and seven control hemispheres were dissected into coronal slices. On sections stained for Giemsa, the cortex was outlined and optical disectors applied using systematic uniform random sampling. Neurons were counted using an oil immersion objective (× 60) following stereological principles. Grey and WM demyelination was outlined on myelin basic protein immunostained sections, and expressed as percentages of cortex and WM respectively. RESULTS: In MS, the mean number of neurons was 14.9 ± 1.9 billion vs. 24.4 ± 2.4 billion in controls (P < 0.011), a 39% difference. The density of neurons was smaller by 28% (P < 0.001) and cortical volume by 26% (P = 0.1). Strong association was detected between number of neurons and cortical volume (P < 0.0001). Demyelination affected 40 ± 13% of the MS neocortex and 9 ± 12% of the WM, however, neither correlated with neuronal loss. Only weak association was detected between number of neurons and WM volume. CONCLUSION: Neocortical neuronal loss in MS is massive and strongly predicted by cortical volume. Cortical volume decline detected in vivo may be similarly indicative of neuronal loss. Lack of association between neuronal density and demyelination suggests these features are partially independent, at least in chronic MS.
Authors: Kathrine E Attfield; Lise Torp Jensen; Max Kaufmann; Manuel A Friese; Lars Fugger Journal: Nat Rev Immunol Date: 2022-05-04 Impact factor: 53.106
Authors: Dejan Jakimovski; Niels Bergsland; Michael G Dwyer; Jesper Hagemeier; Deepa P Ramasamy; Kinga Szigeti; Thomas Guttuso; David Lichter; David Hojnacki; Bianca Weinstock-Guttman; Ralph H B Benedict; Robert Zivadinov Journal: Neurobiol Aging Date: 2020-02-08 Impact factor: 4.673
Authors: Tanja Hochstrasser; Sebastian Rühling; Kerstin Hecher; Kai H Fabisch; Uta Chrzanowski; Matthias Brendel; Florian Eckenweber; Christian Sacher; Christoph Schmitz; Markus Kipp Journal: Cells Date: 2019-09-03 Impact factor: 6.600
Authors: Arman Eshaghi; Rogier A Kievit; Ferran Prados; Carole H Sudre; Jennifer Nicholas; M Jorge Cardoso; Dennis Chan; Richard Nicholas; Sebastien Ourselin; John Greenwood; Alan J Thompson; Daniel C Alexander; Frederik Barkhof; Jeremy Chataway; Olga Ciccarelli Journal: Proc Natl Acad Sci U S A Date: 2019-05-09 Impact factor: 11.205
Authors: João J Cerqueira; D Alastair S Compston; Ruth Geraldes; Mario M Rosa; Klaus Schmierer; Alan Thompson; Michela Tinelli; Jacqueline Palace Journal: J Neurol Neurosurg Psychiatry Date: 2018-04-04 Impact factor: 10.154